acarix Press August 6, 2024 28 Aug 2023 Acarix welcomes Dr. Deepak R. Talreja MD as new Medical Advisor Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the appointment of Dr. Deepak R. Talreja, MD, as new Med... Continue reading
acarix Press August 6, 2024 23 Aug 2023 Acarix to participate in Erik Penser Bank’s Company Day on August 24, 2023 Acarix, a leader in acoustic and AI-based cardiac diagnostics, is pleased to announce participation in the upcoming Erik Penser Bank Co... Continue reading
acarix Press August 6, 2024 23 Aug 2023 Acarix deltar på Erik Penser Banks Bolagsdag den 24 augusti 2023 Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar sitt deltagande i den kommande Erik Penser Banks Bolagsdag den 2... Continue reading
acarix Press August 6, 2024 09 Jun 2023 Announcement from Acarix’s extra general meeting The extra general meeting of Acarix AB (the "Company") was held today on 9 June 2023 and the following resolutions were passe... Continue reading
acarix Press August 6, 2024 09 Jun 2023 Kommuniké från extra bolagsstämma i Acarix Extra bolagsstämma i Acarix AB ("Bolaget") hölls idag den 9 juni 2023 varvid aktieägarna fattade följande beslut. Beslut om g... Continue reading
acarix Press August 6, 2024 22 May 2023 Notice of Extra General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby invited to the extra general meeting to be h... Continue reading
acarix Press August 6, 2024 22 May 2023 Kallelse till extra bolagsstämma i Acarix AB Aktieägarna i Acarix AB, org.nr 559009-0667, ("Bolaget") kallas härmed till extra bolagsstämma fredagen den 9 juni 2023 kl. 1... Continue reading
acarix Press August 6, 2024 22 May 2023 Acarix raises approximately SEK 22 million through exercise of warrants and resolves on a directed share issue In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrants of series 2022:U (the ... Continue reading
acarix Press August 6, 2024 22 May 2023 Acarix tillförs cirka 22 MSEK genom utnyttjandet av teckningsoptioner och beslutar om riktad nyemission Acarix AB (publ) (“Acarix” eller “Bolaget”) genomförde under december 2022 en företrädesemission av aktier och teckningsoptioner av ser... Continue reading
acarix Press August 6, 2024 17 May 2023 State-of-the-Art Cardiology Clinic enhances patient care with CADScor System Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today that Abo-Auda Associates Cardiologists in Texoma, Texas ... Continue reading
acarix Press August 6, 2024 17 May 2023 State-of-the-Art kardiologiklinik förbättrar patientvården med CADScor System Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att Abo-Auda Associates Cardiologists i Texoma, Texas komme... Continue reading
acarix Press August 6, 2024 16 May 2023 Acarix Awarded Business Sweden 2023 Catalyst Program Award Acarix, a leader in acoustic and AI-based cardiac diagnostics, is pleased to announce they have been awarded the 2023 Catalyst Program ... Continue reading